Abstract
Owing to their high extinction coefficients, long absorption wavelengths, and modification tunable photophysical and photochemical properties, phthalocyanines (Pcs) have been widely used as photosensitizers for photodynamic therapy (PDT). Advances made in the past five years on the development of Pcs as medicinal photosensitizers are reviewed and the main design considerations for medicinal applications of these substances are discussed.
Original language | English |
---|---|
Pages (from-to) | 147-160 |
Number of pages | 14 |
Journal | Coordination Chemistry Reviews |
Volume | 379 |
DOIs | |
State | Published - 15 Jan 2019 |
Bibliographical note
Funding Information:This Study was financially supported by the National Natural Science Foundation of China (Grant Nos. 21473033 , 21172037 ), Specialized Research Fund for the Doctoral Program of Higher Education (Grant No. 201135141001 ), and a grant from the National Creative Research Initiative programs of the National Research Foundation of Korea (NRF) funded by the Korean government (MSIP) (No. 2012R1A3A2048814 ).
Funding Information:
This Study was financially supported by the National Natural Science Foundation of China (Grant Nos. 21473033, 21172037), Specialized Research Fund for the Doctoral Program of Higher Education (Grant No. 201135141001), and a grant from the National Creative Research Initiative programs of the National Research Foundation of Korea (NRF) funded by the Korean government (MSIP) (No. 2012R1A3A2048814).
Publisher Copyright:
© 2017 Elsevier B.V.
Keywords
- Medicinal
- Photodynamic therapy
- Photosensitizer
- Phthalocyanine
- Targeting
- Water soluble